Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients

BACKGROUND: The chemotherapy resistance and toxicity of chemotherapy are major problems in breast cancer treatment. However, candidate biomarkers for predicting clinical outcomes and better prognosis remain lacking. METHODS: In this study, we analyzed possible impact of 8 genetic variants of fibrobl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lu, Qi, Huijie, Zhang, Liudi, Li, Haixia, Shao, Jie, Chen, Haifei, Zhong, Mingkang, Shi, Xiaojin, Ye, Ting, Li, Qunyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202826/
https://www.ncbi.nlm.nih.gov/pubmed/30359238
http://dx.doi.org/10.1186/s12885-018-4951-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202826/
https://www.ncbi.nlm.nih.gov/pubmed/30359238
http://dx.doi.org/10.1186/s12885-018-4951-z

Ejemplares similares